[HTML][HTML] In vivo dosimetry in brachytherapy: Requirements and future directions for research, development, and clinical practice
GP Fonseca, JG Johansen, RL Smith… - Physics and imaging in …, 2020 - Elsevier
Brachytherapy can deliver high doses to the target while sparing healthy tissues due to its
steep dose gradient leading to excellent clinical outcome. Treatment accuracy depends on …
steep dose gradient leading to excellent clinical outcome. Treatment accuracy depends on …
Brachytherapy future directions
JAM Cunha, R Flynn, C Bélanger, C Callaghan… - Seminars in radiation …, 2020 - Elsevier
Brachytherapy has advanced dramatically in the last decade due largely to improvements in
applicators, imaging, treatment planning, and use of clinical trials. In addition, current …
applicators, imaging, treatment planning, and use of clinical trials. In addition, current …
A novel 169Yb‐based dynamic‐shield intensity modulated brachytherapy delivery system for prostate cancer
G Famulari, M Duclos, SA Enger - Medical physics, 2020 - Wiley Online Library
Purpose Intensity modulated brachytherapy (IMBT) is a novel high dose rate brachytherapy
(HDR BT) technique which incorporates static or dynamic shielding to increase tumor …
(HDR BT) technique which incorporates static or dynamic shielding to increase tumor …
Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques
Purpose To systematically review scientific literature on the use of intensity-modulated
brachytherapy (IMBT), including static and dynamic shielding approaches, to enhance …
brachytherapy (IMBT), including static and dynamic shielding approaches, to enhance …
Optimization in treatment planning of high dose‐rate brachytherapy—Review and analysis of mathematical models
Treatment planning in high dose‐rate brachytherapy has traditionally been conducted with
manual forward planning, but inverse planning is today increasingly used in clinical practice …
manual forward planning, but inverse planning is today increasingly used in clinical practice …
Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with 192Ir, 60Co, and 169Yb HDR sources
H Safigholi, DY Han, S Mashouf, A Soliman… - Medical …, 2017 - Wiley Online Library
Purpose To evaluate plan quality of a novel MRI‐compatible direction modulated
brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR …
brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR …
Comparison of 192Ir, 169Yb, and 60Co high‐dose rate brachytherapy sources for skin cancer treatment
H Safigholi, AS Meigooni, WY Song - Medical Physics, 2017 - Wiley Online Library
Purpose To evaluate the possibility of utilizing the high‐dose rate (HDR) 169Yb and 60Co
sources, in addition to 192Ir, for the treatment of skin malignancies with conical applicators …
sources, in addition to 192Ir, for the treatment of skin malignancies with conical applicators …
Evolution of brachytherapy applicators for the treatment of cervical cancer
A Mourya, LM Aggarwal… - Journal of Medical Physics, 2021 - journals.lww.com
Brachytherapy applicators have come a long way since Danlos developed early
intracavitary applicators to treat cervical cancer patients. Therefore, this review will help in …
intracavitary applicators to treat cervical cancer patients. Therefore, this review will help in …
A directional 103Pd brachytherapy device: Dosimetric characterization and practical aspects for clinical use
MJ Rivard - Brachytherapy, 2017 - Elsevier
Purpose A brachytherapy (BT) device has been developed with shielding to provide
directional BT for preferentially irradiating malignancies while sparing healthy tissues. The …
directional BT for preferentially irradiating malignancies while sparing healthy tissues. The …
Efficient 169Yb high‐dose‐rate brachytherapy source production using reactivation
Purpose To present and quantify the effectiveness of a method for the efficient production of
169Yb high‐dose‐rate brachytherapy sources with 27 Ci activity upon clinical delivery …
169Yb high‐dose‐rate brachytherapy sources with 27 Ci activity upon clinical delivery …